ALK and non-small cell lung carcinoma: As already happened in the advanced setting, for oncogene-addicted disease, experimentations have focused on Epidermal Growth Factor Receptor (EGFR) gene mutations (EGFRm) and Anaplastic Lymphoma Kinase (ALK) rearrangements (ALKr), the most commonly detected in NSCLC pts.